Latest news

Evommune soars past IPO slowdown with $150M debut amid federal shutdown

Evommune soars past IPO slowdown with $150M debut amid federal shutdown

Joachim Eeckhout
Daily Snap - 6. November 2025

Daily Snap - 6. November 2025

Joachim Eeckhout
Merck (MSD) accelerates with a $700M boost for its cancer ADC drug

Merck (MSD) accelerates with a $700M boost for its cancer ADC drug

Joachim Eeckhout
Braveheart Bio loads up with $185M to challenge BMS’ heart drug with bold new contender

Braveheart Bio loads up with $185M to challenge BMS’ heart drug with bold new contender

Joachim Eeckhout
Roche supports AI-powered brain drug breakthrough with $55M

Roche supports AI-powered brain drug breakthrough with $55M

Joachim Eeckhout
FDA U-turn stalls promising Huntington's gene therapy from uniQure

FDA U-turn stalls promising Huntington's gene therapy from uniQure

Joachim Eeckhout
Daily Snap - 4. November 2025

Daily Snap - 4. November 2025

Joachim Eeckhout
Daily Snap - 3. November 2025

Daily Snap - 3. November 2025

Joachim Eeckhout
Corporate VCs fill biotech funding gap amid venture slowdown

Corporate VCs fill biotech funding gap amid venture slowdown

Joachim Eeckhout
4DMT secures $420M Otsuka deal to fast-track retinal gene therapy

4DMT secures $420M Otsuka deal to fast-track retinal gene therapy

Joachim Eeckhout
Daily Snap - 31. October 2025

Daily Snap - 31. October 2025

Joachim Eeckhout
FDA cuts red tape to fast-track cheaper biosimilar drugs

FDA cuts red tape to fast-track cheaper biosimilar drugs

Joachim Eeckhout
FirstBack
56789101112
Next Last